Sung-Cheng Huang

Title: Innovations of Sung-Cheng Huang

Introduction

Sung-Cheng Huang is a notable inventor based in Sherman Oaks, California. He has made significant contributions to the field of medical imaging, particularly in the analysis and diagnosis of neurological diseases. With a total of five patents to his name, Huang's work has the potential to greatly impact the way neurodegenerative diseases are diagnosed and classified.

Latest Patents

Huang's latest patents include a method for positron emission tomography (PET) imaging analysis for classifying and diagnosing neurological diseases. This innovative method utilizes PET images obtained with a radiotracer to determine the progressive course of regional brain PET activities for neurodegenerative diseases such as mild cognitive impairment (MCI), Alzheimer's disease (AD), and chronic traumatic encephalopathy (CTE). The method allows for automatic staging of these diseases based on regional intensity and spatial patterns of brain signals measured by PET imaging. Additionally, Huang has developed compositions for labeling β-amyloid plaques and neurofibrillary tangles, which are crucial for understanding the pathology of Alzheimer's disease.

Career Highlights

Throughout his career, Huang has worked with prestigious institutions, including the University of California and Picker Corporation. His research has focused on advancing medical imaging techniques and improving diagnostic accuracy for neurological conditions.

Collaborations

Huang has collaborated with notable colleagues such as Jorge R. Barrio and Gary W. Small, contributing to a rich exchange of ideas and innovations in the field of medical imaging.

Conclusion

Sung-Cheng Huang's contributions to the field of medical imaging and his innovative patents position him as a key figure in the diagnosis and classification of neurological diseases. His work continues to pave the way for advancements in medical technology and patient care.